{"id":749776,"date":"2023-04-20T16:45:04","date_gmt":"2023-04-20T20:45:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/"},"modified":"2023-04-20T16:45:04","modified_gmt":"2023-04-20T20:45:04","slug":"cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/","title":{"rendered":"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">FREMONT, Calif., April  20, 2023  (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced it will report financial results for the first quarter 2023 after market close on Tuesday, May 9<sup>th<\/sup>, 2023. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.<\/p>\n<p>Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com<\/p>\n<p>\n        <strong>About Cytek Biosciences<\/strong><br \/>\n        <br \/>Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling\u2122 (FSP\u2122) technology. Cytek\u2019s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek\u2019s FSP platform includes its core instruments, the Aurora and Northern Lights\u2122 systems; its cell sorter, the Aurora CS; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. With the acquisition of DiaSorin\u2019s Flow Cytometry &amp; Imaging business unit in February 2023, Cytek added Amnis<sup>\u00ae<\/sup> imaging flow cytometers and Guava<sup>\u00ae<\/sup> flow cytometers to its solution lineup. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.<\/p>\n<p>Other than Cytek\u2019s Northern Lights CLC system and certain reagents for use therewith, which are available for clinical use in countries where the regulatory approval has been obtained from the local regulatory authorities, including China and the European Union, Cytek\u2019s products are for research use only and not for use in diagnostic procedures. Please contact your local sales representatives for the status of local regulatory approval.<\/p>\n<p>Cytek, Full Spectrum Profiling, FSP, Northern Lights, Amnis and Guava are trademarks or registered trademarks of Cytek Biosciences, Inc.<\/p>\n<p>In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and corporate Twitter account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek\u2019s website, LinkedIn page, and Twitter account in addition to following its SEC filings, news releases, public conference calls and webcasts.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Paul D. Goodson<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ppqTCCqvd4wlhIqhGE8zNbpWmFPOb2BHdH6vedDJpplOMxdagbSPbRtMP72hbimQlc5cE9S17qfWgVfbqPWnplz5KI7LdNStKBNERjMi1KQ=\" rel=\"nofollow noopener\" target=\"_blank\">pgoodson@cytekbio.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Stephanie Olsen<br \/>Lages &amp; Associates<br \/>(949) 453-8080<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NbQlB2mYOxhcLYAYvp4cGcpcsEy1oITkSge9SqLpmcuOYQwudYskFW10wHfz5WjeL2rNzhibWk6Jl6Ei9NK_GB0AjcIbxFwSstXe79G8hIwQihG0UoS5HHoDFwq0PhF4f9w4eMEaA9jdp2e6RR_-lNl-554S-6yqMhEZsGWxi6_oflS5sb_dgt56wm_ldrFlkcrw3tUmHTmyIk2xQR4WHYrr1_N2fkquaBVb-QMUHktEeLXm_cBFbu9eJw-n6mRw\" rel=\"nofollow noopener\" target=\"_blank\">stephanie@lages.com<\/a>\u00a0<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YjNmNWU2MGQtMDQ1Ni00MzU1LThlY2UtY2IxN2MxMWVjMmNiLTExMDczNTc=\/tiny\/Cytek-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FREMONT, Calif., April 20, 2023 (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced it will report financial results for the first quarter 2023 after market close on Tuesday, May 9th, 2023. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com About Cytek Biosciences Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling\u2122 (FSP\u2122) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-749776","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FREMONT, Calif., April 20, 2023 (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced it will report financial results for the first quarter 2023 after market close on Tuesday, May 9th, 2023. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com About Cytek Biosciences Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling\u2122 (FSP\u2122) &hellip; Continue reading &quot;Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-20T20:45:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023\",\"datePublished\":\"2023-04-20T20:45:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/\"},\"wordCount\":463,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/\",\"name\":\"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY=\",\"datePublished\":\"2023-04-20T20:45:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/","og_locale":"en_US","og_type":"article","og_title":"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk","og_description":"FREMONT, Calif., April 20, 2023 (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced it will report financial results for the first quarter 2023 after market close on Tuesday, May 9th, 2023. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com About Cytek Biosciences Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling\u2122 (FSP\u2122) &hellip; Continue reading \"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-20T20:45:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023","datePublished":"2023-04-20T20:45:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/"},"wordCount":463,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/","name":"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY=","datePublished":"2023-04-20T20:45:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjUwOSM1NTM5MDMwIzIwOTU3ODY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-first-quarter-2023-financial-results-on-may-9-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=749776"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749776\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=749776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=749776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=749776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}